Vaks Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-07-2024
- Paid Up Capital ₹ 0.10 M
as on 04-07-2024
- Company Age 23 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 65.39%
(FY 2022)
- Profit 76.78%
(FY 2022)
- Ebitda 48.41%
(FY 2022)
- Net Worth 12.70%
(FY 2022)
- Total Assets 38.99%
(FY 2022)
About Vaks Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arjun Panikar and Siddharth Panikar serve as directors at the Company.
- CIN/LLPIN
U51397MH2001PTC133776
- Company No.
133776
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vaks Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arjun Panikar  | Director | 21-Aug-2018 | Current |
| Siddharth Panikar | Director | 20-Jul-2007 | Current |
Financial Performance and Corporate Structure Insights of Vaks Pharma.
Vaks Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 65.39% increase. The company also saw a substantial improvement in profitability, with a 76.78% increase in profit. The company's net worth Soared by an impressive increase of 12.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaks Pharma?
In 2022, Vaks Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mitoch Pharma Private LimitedActive 32 years 2 monthsArjun Panikar and Siddharth Panikar are mutual person
Mccoy Pharma Private LimitedActive 30 years 5 monthsArjun Panikar and Siddharth Panikar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vaks Pharma?
Unlock and access historical data on people associated with Vaks Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaks Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaks Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
